Methylphenidate in children with hyperactivity: review and cost-utility analysis (Q34086479)

30 July 2017

1 reference

title

Methylphenidate in children with hyperactivity: review and cost-utility analysis (English)

1 reference

30 July 2017

R Milne

2

0 references

author name string

A Gilmore

series ordinal

1

1 reference

30 July 2017

1 March 2001

1 reference

Pharmacoepidemiology and Drug Safety

30 July 2017

1 reference

30 July 2017

10

1 reference

30 July 2017

2

1 reference

30 July 2017

85-94

1 reference

Classroom academic performance: improvement with both methylphenidate and dextroamphetamine in ADHD boys.

30 July 2017

1 reference

Developmental changes in the mother-child interactions of hyperactive boys: effects of two dose levels of Ritalin.

21 January 2018

1 reference

Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.

21 January 2018

1 reference

Does methylphenidate normalize the classroom performance of children with attention deficit disorder?

21 January 2018

1 reference

Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children

21 January 2018

1 reference

Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.

21 January 2018

1 reference

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

21 January 2018

1 reference

Vicissitudes of follow-up studies: differential effects of parent training and stimulant medication with hyperactives.

21 January 2018

1 reference

Childhood hyperactivity and psychostimulants: a review of extended treatment studies

21 January 2018

1 reference

Young adult outcome of hyperactive children who received long-term stimulant treatment.

21 January 2018

1 reference

One-year follow-up of hyperactive boys treated with imipramine or methylphenidate

21 January 2018

1 reference

Three-year multimodality treatment study of 100 hyperactive boys.

21 January 2018

1 reference

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Methylphenidate and growth in hyperactive children. A controlled withdrawal study

21 January 2018

1 reference

Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height

21 January 2018

1 reference

Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?

21 January 2018

1 reference

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

21 January 2018

1 reference

21 January 2018

Cost-utility analysis

1 reference

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

21 January 2018

1 reference

Globalisation of international health

21 January 2018

1 reference

Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate

21 January 2018

1 reference

DEC methods for appraising new drugs. Are a foundation for the nice appraisal committee

21 January 2018

1 reference

Economics, health, and the economics of health

21 January 2018

1 reference

NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale.

21 January 2018

1 reference

Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour

21 January 2018

1 reference

Hyperactive girls and boys: stimulant drug effects on mother-child interactions

21 January 2018

1 reference

Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behavior and cognitive performance effects

21 January 2018

1 reference

Growth of hyperactive children on maintenance regimen of methylphenidate

21 January 2018

1 reference

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

21 January 2018

1 reference

DEC methods for appraising new drugs. Are justified

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.564

1 reference

30 July 2017

1 reference

PubMed ID

11499858